EP2788030

USES OF IMMUNOCONJUGATES TARGETING CD138

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    7.12.2012
  • EP published:
    20.6.2018
  • EP application number:
    12798723.8
  • Max expiry date:
    6.12.2032
  • Title:
    USES OF IMMUNOCONJUGATES TARGETING CD138

Timeline

Today
7.12.2012EP application
20.6.2018EP Publication

Owner

  • Name:
    Biotest AG
  • Address:
    Landsteinerstr. 5, 63303, Dreieich, DE
  • Name:
    ImmunoGen, Inc.
  • Address:
    830 Winter Street, 02451, Waltham, MA, US

Inventor

  • Name:
    SCHULZ, Gregor
  • Address:
    Umkirch, DE
  • Name:
    OSTERROTH, Frank
  • Address:
    Dietzenbach, DE
  • Name:
    HAEDER, Thomas
  • Address:
    Dreieich, DE
  • Name:
    BRUECHER, Christoph
  • Address:
    Eschborn, DE
  • Name:
    NIEMANN, Gabriele
  • Address:
    Walzbachtal, DE
  • Name:
    ENGLING, Andre
  • Address:
    Bad Homburg, DE
  • Name:
    UHEREK, Christoph
  • Address:
    Seligenstadt, DE
  • Name:
    DAELKEN, Benjamin
  • Address:
    Frankfurt am Main, DE
  • Name:
    WARTENBERG-DEMAND, Andrea
  • Address:
    Schrecksbach, DE
  • Name:
    ZUBER, Chantal
  • Address:
    Ulm, DE
  • Name:
    GUTSCHER, Marcus
  • Address:
    Langen, DE
  • Name:
    BERNOESTER, Katrin
  • Address:
    Wiesbaden, DE
  • Name:
    KOENIG, Martin
  • Address:
    Wiesbaden, DE

Priority

  • Number:
    201161568640 P
  • Date:
    8.12.2011
  • Country:
    US
  • Number:
    201261722367 P
  • Date:
    5.11.2012
  • Country:
    US

Classification

  • Categories:
    A61K 47/68, A61P 35/00

Upload documents